These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 395959)

  • 41. [Long-term drug therapy of arrhythmias (with special reference to ventricular tachyarrhythmias].
    Gertsch M
    Schweiz Med Wochenschr; 1984 Jan; 114(3):77-86. PubMed ID: 6199838
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserin. Multicenter Ketanserin Research Group.
    Zehender M; Meinertz T; Hohnloser S; Geibel A; Hartung J; Seiler KU; Just H
    Clin Physiol Biochem; 1990; 8 Suppl 3():90-100. PubMed ID: 2132179
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Results of the clinical study of a new anti-arrhythmia preparation allapinin].
    Mazur NA; Ivanova LA; Pavlova TS
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):30-3. PubMed ID: 3541962
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ionic changes evoked by isoprenaline in rat hearts in vivo and in vitro and their reduction by creatinol O-phosphate.
    Godfraind T; Ghysel-Burton J; Sturbois X
    Arzneimittelforschung; 1979; 29(9a):1468-70. PubMed ID: 575494
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiarrhythmic effects of timolol in patients with ventricular arrhythmias.
    Ribeiro LG; Price BA; Irvin JD
    Arq Bras Cardiol; 1988 Oct; 51(4):359-64. PubMed ID: 3075121
    [No Abstract]   [Full Text] [Related]  

  • 46. Göteborg Metoprolol Trial: effects on arrhythmias.
    Herlitz J; Edvardsson N; Holmberg S; Rydén L; Waagstein F; Waldenström A; Swedberg K; Hjalmarson A
    Am J Cardiol; 1984 Jun; 53(13):27D-31D. PubMed ID: 6731325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Characterization and therapy of ventricular arrhythmias due to transient myocardial ischemic attacks in variant angina].
    Turitto G; Dini P; Rocca P; Vicari M; Zanchi E; Prati PL
    G Ital Cardiol; 1984 Sep; 14(9):663-70. PubMed ID: 6510621
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nifedipine as an adjunct to St. Thomas' Hospital cardioplegia. A double-blind, placebo-controlled, randomized clinical trial.
    Flameng W; De Meyere R; Daenen W; Sergeant P; Ngalikpima V; Geboers J; Suy R; Stalpaert G
    J Thorac Cardiovasc Surg; 1986 May; 91(5):723-31. PubMed ID: 3517508
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The prevention by creatinol O-phosphate of myocardial lesions evoked by isoprenaline.
    Godfraind T; Sturbois X
    Arch Int Pharmacodyn Ther; 1979 Feb; 237(2):288-97. PubMed ID: 573603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of the beta-adrenoceptor-blocking agent Sotalol on ventricular arrhythmias in patients with chronic ischemic heart disease. A placebo-controlled, double-blind cross-over study.
    Burckhardt D; Pfisterer M; Hoffmann A; Burkart F; Emmenegger H; Jost M; Bolli P; Buehler FR
    Cardiology; 1983; 70 Suppl 1():114-21. PubMed ID: 6342778
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmacological and toxicological properties of creatinol O-phosphate. A review.
    Marzo A; Ghirardi P
    Arzneimittelforschung; 1979; 29(9a):1449-52. PubMed ID: 395957
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activity of creatinol O-phosphate on persistent ventricular premature beats in ischemic heart disease. Double blind clinical trial.
    Di Maio F; Neri A; Soccorsi P; Sciacca A
    Arzneimittelforschung; 1979; 29(9a):1488-90. PubMed ID: 395959
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antiarrhythmic effectiveness of creatinol O-phosphate in man.
    Cadel A; Palumbo A; Zerilli G; Pria R; Fanciulli R; Conversano S; Galbiati R
    Arzneimittelforschung; 1979; 29(9a):1485-7. PubMed ID: 94266
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Creatinol O-phosphate therapy in patients with inadequate coronary circulation. Double-blind clinical trial.
    Barlattani M; Guglielmi G; Mammarella A
    Arzneimittelforschung; 1979; 29(9a):1483-5. PubMed ID: 395958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preliminary report on electrophysiological effectiveness of creatinol O-phosphate (COP) in human subjects.
    Botti G; Bonatti V
    Arzneimittelforschung; 1979; 29(9a):1491-4. PubMed ID: 575499
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Controlled clinical study of the use of creatinol-O-phosphate in subjects with deficient myocardial circulation].
    Guglielmi G; Mammarella A
    Clin Ter; 1979 Nov; 91(4):355-82. PubMed ID: 396100
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.